Cardinal Health, Inc. $CAH Stake Raised by Vontobel Holding Ltd.

Vontobel Holding Ltd. increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 1,299.3% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 932,746 shares of the company’s stock after buying an additional 866,089 shares during the quarter. Cardinal Health accounts for 0.7% of Vontobel Holding Ltd.’s portfolio, making the stock its 27th biggest holding. Vontobel Holding Ltd.’s holdings in Cardinal Health were worth $207,536,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently added to or reduced their stakes in the company. LWM Advisors Inc. grew its holdings in shares of Cardinal Health by 4.4% during the 2nd quarter. LWM Advisors Inc. now owns 1,028 shares of the company’s stock worth $244,000 after purchasing an additional 43 shares in the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Cardinal Health by 2.5% in the second quarter. Parkside Financial Bank & Trust now owns 1,793 shares of the company’s stock valued at $426,000 after purchasing an additional 43 shares in the last quarter. Annex Advisory Services LLC lifted its position in Cardinal Health by 1.5% in the third quarter. Annex Advisory Services LLC now owns 2,914 shares of the company’s stock worth $648,000 after purchasing an additional 44 shares during the period. Kathmere Capital Management LLC boosted its stake in Cardinal Health by 1.2% during the first quarter. Kathmere Capital Management LLC now owns 4,242 shares of the company’s stock worth $896,000 after buying an additional 49 shares in the last quarter. Finally, V Square Quantitative Management LLC boosted its stake in Cardinal Health by 2.6% during the first quarter. V Square Quantitative Management LLC now owns 2,002 shares of the company’s stock worth $423,000 after buying an additional 50 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Insider Activity at Cardinal Health

In other Cardinal Health news, CEO Deborah Weitzman sold 7,354 shares of Cardinal Health stock in a transaction on Tuesday, August 18th. The stock was sold at an average price of $235.45, for a total value of $1,731,499.30. Following the completion of the transaction, the chief executive officer directly owned 77,901 shares of the company’s stock, valued at $18,341,790.45. The trade was a 8.63% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Jason Hollar sold 80,000 shares of the company’s stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $235.74, for a total transaction of $18,859,200.00. Following the sale, the chief executive officer directly owned 235,132 shares of the company’s stock, valued at $55,430,017.68. This represents a 25.39% decrease in their position. The SEC filing for this sale provides additional information. In the last three months, insiders sold 210,271 shares of company stock valued at $49,626,657. 0.12% of the stock is currently owned by company insiders.

Cardinal Health Trading Up 0.1%

Shares of NYSE:CAH traded up $0.15 during midday trading on Friday, hitting $253.86. The company had a trading volume of 1,336,496 shares, compared to its average volume of 1,856,656. The stock has a market cap of $58.78 billion, a price-to-earnings ratio of 35.11, a PEG ratio of 1.53 and a beta of 0.50. The firm has a fifty day simple moving average of $234.54 and a 200 day simple moving average of $222.22. Cardinal Health, Inc. has a 12 month low of $152.46 and a 12 month high of $258.30.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, beating analysts’ consensus estimates of $2.42 by $0.49. The firm had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The business’s revenue was up 5.8% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.08 earnings per share. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Equities analysts forecast that Cardinal Health, Inc. will post 12.55 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Thursday, October 15th. Shareholders of record on Thursday, October 1st were issued a $0.5158 dividend. This represents a $2.06 dividend on an annualized basis and a yield of 0.8%. The ex-dividend date of this dividend was Thursday, October 1st. Cardinal Health’s dividend payout ratio is currently 28.49%.

Wall Street Analyst Weigh In

CAH has been the subject of a number of analyst reports. Mizuho raised their price objective on shares of Cardinal Health from $240.00 to $250.00 and gave the stock an “outperform” rating in a report on Wednesday, August 12th. Wells Fargo & Company increased their price target on shares of Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research report on Wednesday, August 12th. Weiss Ratings upgraded shares of Cardinal Health from a “buy (b)” rating to a “buy (b+)” rating in a research note on Thursday, October 8th. Wall Street Zen downgraded Cardinal Health from a “strong-buy” rating to a “buy” rating in a report on Saturday. Finally, TD Cowen increased their target price on Cardinal Health from $275.00 to $280.00 and gave the stock a “buy” rating in a report on Thursday, August 13th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Cardinal Health presently has an average rating of “Moderate Buy” and a consensus target price of $267.50.

Cardinal Health Profile

Cardinal Health, Inc is a healthcare services and products company that supports pharmacies, hospitals, ambulatory surgery centers, physician offices and other healthcare providers. Its operations are primarily organized into Pharmaceutical and Medical segments.

The Pharmaceutical segment distributes branded, generic, specialty and over-the-counter medicines, as well as consumer health products. It also provides services related to specialty pharmaceuticals, pharmaceutical sourcing, nuclear and precision health products, and data and analytics for pharmaceutical manufacturers and healthcare organizations.

The Medical segment distributes medical and surgical products, including gloves, apparel, incontinence supplies, laboratory products and other essential items.